To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. Read More
To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. And I’d like to tell you about the best pure-play pharmacy benefit company on the market. Express Scripts (Nasdaq: ESRX) is the largest pharmacy benefit management (PBM) company in the U.S.#-ad_banner-# Put simply, PBMs operate as middlemen between drugmakers and employers. Express Scripts operates a mail-order pharmacy business as well as a network of retail pharmacies. The company also provides a service that processes prescription claims made by its clients’ members. In today’s age of shopping and doing business online, ESRX offers several unique services. The company offers… Read More